Jianguang Sun

Jinan, 250011, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Multi-omics integration identifies cell-type-specific CISD1 and QDPR as druggable regulators linking hepatocellular carcinoma and major depressive disorder.

Multi-omics integration identifies cell-type-specific CISD1 and QDPR as druggable regulators linking hepatocellular carcinoma and major depressive disorder.

Journal: Psychiatry research
Published: February 14, 2026

Targeting multiple regulated cell death pathways in acute pancreatitis: The multi-target potential of natural products from Traditional Chinese Medicine.

Targeting multiple regulated cell death pathways in acute pancreatitis: The multi-target potential of natural products from Traditional Chinese Medicine.

Journal: Pathology, research and practice
Published: December 29, 2025

Immunometabolic heterogeneity in hepatocellular carcinoma: Transforming cold tumors into hot tumors.

Immunometabolic heterogeneity in hepatocellular carcinoma: Transforming cold tumors into hot tumors.

Journal: Critical reviews in oncology/hematology
Published: November 19, 2025

Computed tomography-based artificial intelligence for predicting preoperative microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.

Computed tomography-based artificial intelligence for predicting preoperative microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.

Journal: La Radiologia medica
Published: July 23, 2025

Global research trends and frontiers in ferroptosis in hepatocellular carcinoma: a bibliometric and visualization study.

Global research trends and frontiers in ferroptosis in hepatocellular carcinoma: a bibliometric and visualization study.

Journal: Frontiers in oncology
Published: August 01, 2024

Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database.

Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database.

Journal: Heliyon
Published: June 25, 2024

Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study.

Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study.

Journal: BMC cancer
Published: November 29, 2023

The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.

The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.

Journal: Bioengineered
Published: April 27, 2023

Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study.

Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study.

Journal: BMC public health
Published: November 26, 2022

Complementary and alternative therapies for non-alcoholic fatty liver disease: A Bayesian network meta-analysis protocol.

Complementary and alternative therapies for non-alcoholic fatty liver disease: A Bayesian network meta-analysis protocol.

Journal: Medicine
Published: December 29, 2020

Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis.

Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis.

Journal: Medicine
Published: December 16, 2020

Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in China.

Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in China.

Journal: Trials
Published: January 07, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026